Skip to content

Application of intervention Mapping in prevention of retinopathy in patients with type 2 diabetes mellitus

Application of intervention Mapping in prevention of retinopathy in patients with type 2 diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073311
Enrollment
Unknown
Registered
2023-07-06
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II diabetes

Interventions

Experimental group:Health education program for Diabetic retinopathy based on intervention mapping
Control group:Regular health education

Sponsors

Affiliated Hospital of Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age =18 years old; (2) Meet the diagnostic criteria of type 2 diabetes in the Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition); (3) Diagnosis time =1 year; (4) Clear consciousness, good reading and communication skills; (5) Informed consent and voluntary participation in this study.

Exclusion criteria

Exclusion criteria: (1) suffering from mental diseases; (2) Patients who do not know how to use smart phones and wechat platforms; (3) Diagnosed diabetic retinopathy, severe diabetic complications (diabetic ketoacidosis, hypertonic syndrome, hypoglycemic coma) or diseases of heart, brain, kidney and other important organs; (4) Participate in other similar researchers at the same time.

Design outcomes

Primary

MeasureTime frame
DR Related knowledge - Attitude - behavior questionnaire;

Secondary

MeasureTime frame
Diabetes self-management behavior;Diabetic self-efficacy;Diabetes health literacy;Glycosylated hemoglobin data;

Countries

CHINA

Contacts

Public ContactYing Han

Affiliated Hospital of Guizhou Medical University

1349164714@qq.com+86 851 8677 3824

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026